Literature DB >> 10908357

Recognition of a cognate RNA aptamer by neomycin B: quantitative evaluation of hydrogen bonding and electrostatic interactions.

J A Cowan1, T Ohyama, D Wang, K Natarajan.   

Abstract

Aminoglycosides are an important class of antibiotic that selectively target RNA structural motifs. Recently we have demonstrated copper derivatives of amino-glycosides to be efficient cleavage agents for cognate RNA motifs. To fully develop their potential as pharmaceutical agents it is necessary to understand both the structural mechanisms used by aminoglycosides to target RNA, and the relative contributions of hydrogen bonding and electrostatic interactions to recognition selectivity. Herein we report results from a calorimetric analysis of a stem-loop 23mer RNA aptamer complexed to the aminoglycoside neomycin B. Key thermodynamic parameters for complex formation have been determined by isothermal titration calorimetry, and from the metal-ion dependence of these binding parameters the relative contributions of electrostatics and hydrogen bonding toward binding affinity have been assessed. The principal mechanism for recognition and binding of neomycin B to the RNA major groove is mediated by hydrogen bonding.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908357      PMCID: PMC102689          DOI: 10.1093/nar/28.15.2935

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  In vitro selection of a viomycin-binding RNA pseudoknot.

Authors:  M G Wallis; B Streicher; H Wank; U von Ahsen; E Clodi; S T Wallace; M Famulok; R Schroeder
Journal:  Chem Biol       Date:  1997-05

2.  Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide.

Authors:  R D Peterson; J Feigon
Journal:  J Mol Biol       Date:  1996-12-20       Impact factor: 5.469

3.  Saccharide-RNA recognition in a complex formed between neomycin B and an RNA aptamer.

Authors:  L Jiang; A Majumdar; W Hu; T J Jaishree; W Xu; D J Patel
Journal:  Structure       Date:  1999-07-15       Impact factor: 5.006

4.  Specific binding of aminoglycoside antibiotics to RNA.

Authors:  Y Wang; R R Rando
Journal:  Chem Biol       Date:  1995-05

5.  A novel RNA motif for neomycin recognition.

Authors:  M G Wallis; U von Ahsen; R Schroeder; M Famulok
Journal:  Chem Biol       Date:  1995-08

6.  Modeling RNA-ligand interactions: the Rev-binding element RNA-aminoglycoside complex.

Authors:  F Leclerc; R Cedergren
Journal:  J Med Chem       Date:  1998-01-15       Impact factor: 7.446

7.  Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA.

Authors:  D Fourmy; S Yoshizawa; J D Puglisi
Journal:  J Mol Biol       Date:  1998-03-27       Impact factor: 5.469

8.  Alpha helix-RNA major groove recognition in an HIV-1 rev peptide-RRE RNA complex.

Authors:  J L Battiste; H Mao; N S Rao; R Tan; D R Muhandiram; L E Kay; A D Frankel; J R Williamson
Journal:  Science       Date:  1996-09-13       Impact factor: 47.728

9.  Minimal RNA constructs that specifically bind aminoglycoside antibiotics with high affinities.

Authors:  K Hamasaki; J Killian; J Cho; R R Rando
Journal:  Biochemistry       Date:  1998-01-13       Impact factor: 3.162

10.  Assignment and modeling of the Rev Response Element RNA bound to a Rev peptide using 13C-heteronuclear NMR.

Authors:  J L Battiste; R Tan; A D Frankel; J R Williamson
Journal:  J Biomol NMR       Date:  1995-12       Impact factor: 2.835

View more
  17 in total

1.  Complete thermodynamic characterization of the multiple protonation equilibria of the aminoglycoside antibiotic paromomycin: a calorimetric and natural abundance 15N NMR study.

Authors:  Christopher M Barbieri; Daniel S Pilch
Journal:  Biophys J       Date:  2005-12-02       Impact factor: 4.033

2.  Accelerating Post-SELEX Aptamer Engineering Using Exonuclease Digestion.

Authors:  Juan Canoura; Haixiang Yu; Obtin Alkhamis; Daniel Roncancio; Rifat Farhana; Yi Xiao
Journal:  J Am Chem Soc       Date:  2020-12-30       Impact factor: 15.419

3.  Selective transformations of complex molecules are enabled by aptameric protective groups.

Authors:  Andreas A Bastian; Alessio Marcozzi; Andreas Herrmann
Journal:  Nat Chem       Date:  2012-07-22       Impact factor: 24.427

4.  Kinetics and Mechanisms of Oxidative Cleavage of HIV RRE RNA by Rev-Coupled Transition Metal Chelates.

Authors:  Jeff C Joyner; Kevin D Keuper; J A Cowan
Journal:  Chem Sci       Date:  2013-04-01       Impact factor: 9.825

Review 5.  Advances and Challenges in Small-Molecule DNA Aptamer Isolation, Characterization, and Sensor Development.

Authors:  Haixiang Yu; Obtin Alkhamis; Juan Canoura; Yingzhu Liu; Yi Xiao
Journal:  Angew Chem Int Ed Engl       Date:  2021-02-09       Impact factor: 15.336

6.  Targeted cleavage of HIV RRE RNA by Rev-coupled transition metal chelates.

Authors:  Jeff C Joyner; J A Cowan
Journal:  J Am Chem Soc       Date:  2011-06-06       Impact factor: 15.419

Review 7.  Carbohydrate recognition by boronolectins, small molecules, and lectins.

Authors:  Shan Jin; Yunfeng Cheng; Suazette Reid; Minyong Li; Binghe Wang
Journal:  Med Res Rev       Date:  2010-03       Impact factor: 12.944

8.  Binding of aminoglycoside antibiotics to helix 69 of 23S rRNA.

Authors:  Ann E Scheunemann; William D Graham; Franck A P Vendeix; Paul F Agris
Journal:  Nucleic Acids Res       Date:  2010-01-27       Impact factor: 16.971

9.  No Structure-Switching Required: A Generalizable Exonuclease-Mediated Aptamer-Based Assay for Small-Molecule Detection.

Authors:  Juan Canoura; Zongwen Wang; Haixiang Yu; Obtin Alkhamis; Fengfu Fu; Yi Xiao
Journal:  J Am Chem Soc       Date:  2018-07-26       Impact factor: 15.419

10.  Toggled RNA aptamers against aminoglycosides allowing facile detection of antibiotics using gold nanoparticle assays.

Authors:  Nicola Derbyshire; Simon J White; David H J Bunka; Lei Song; Sara Stead; Jonathan Tarbin; Matthew Sharman; Dejian Zhou; Peter G Stockley
Journal:  Anal Chem       Date:  2012-07-25       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.